Literature DB >> 7590479

Quality of life of women with ovarian cancer.

A B Kornblith1, H T Thaler, G Wong, V Vlamis, J M Lepore, D B Loseth, T Hakes, W J Hoskins, R K Portenoy.   

Abstract

The primary objectives of this study were to determine the nature and extent of physical problems and psychological distress experienced by women with ovarian cancer and to identify medical and sociodemographic factors that were predictive of distress. Quality of life was assessed at 3-month intervals, for a maximum of 12 months in 151 ovarian cancer patients, most with advanced-stage disease (86%). Patients' pain, other physical symptoms, level of physical functioning, psychological state, and social functioning were evaluated using the following measures: a detailed pain questionnaire, Memorial Pain Assessment Card, Memorial Symptom Assessment Scale, Mental Health Inventory (MHI), Functional Living Index--Cancer (FLIC), and the Karnofsky Performance Status. Upon entry, 33% of patients reported significant psychological distress, as indicated by MHI Psychological Distress scores (MHI-PD) equal or greater to 1.5 standard deviations above the mean of a nationwide community sample. Impaired physical functioning (FLIC subscale) was the most important predictor of heightened psychological distress (MHI-PD) at baseline (1.5 SD or greater above the norm) (P = 0.0004) in a stepwise logistic regression involving medical/physical and sociodemographic variables as predictors. Further, significant differences were found in all quality of life scales between patients with Karnofsky Performance Status scores of < or = 80, and those with ratings of 90 or greater (P = 0.036 to P < 0.0001). These data suggest the need for an improved and more frequent assessment of ovarian cancer patients' psychological status, particularly as physical functioning declines, to improve early detection and referral to treatment of those suffering from psychiatric sequelae of cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7590479     DOI: 10.1006/gyno.1995.0014

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  37 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Social networks, stress and health-related quality of life.

Authors:  H Achat; I Kawachi; S Levine; C Berkey; E Coakley; G Colditz
Journal:  Qual Life Res       Date:  1998-12       Impact factor: 4.147

3.  Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy.

Authors:  B Conner-Spady; C Cumming; J M Nabholtz; P Jacobs; D Stewart
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

4.  Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study.

Authors:  Lari Wenzel; Helen Q Huang; Bradley J Monk; Peter G Rose; David Cella
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

5.  Using data from studies of health-related quality of life to describe clinical issues examples from a longitudinal study of patients with advanced stages of cervical cancer.

Authors:  M Klee; M Groenvold; D Machin
Journal:  Qual Life Res       Date:  1999-12       Impact factor: 4.147

Review 6.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

7.  Holding back sharing concerns, dispositional emotional expressivity, perceived unsupportive responses and distress among women newly diagnosed with gynecological cancers.

Authors:  Sharon Manne; Shannon Myers; Melissa Ozga; David Kissane; Debby Kashy; Stephen Rubin; Carolyn Heckman; Norm Rosenblum
Journal:  Gen Hosp Psychiatry       Date:  2013-10-09       Impact factor: 3.238

8.  Quality of life among women after surgery for ovarian cancer.

Authors:  Dena Schulman-Green; Elizabeth Ercolano; Michael Dowd; Peter Schwartz; Ruth McCorkle
Journal:  Palliat Support Care       Date:  2008-09

Review 9.  The taxanes: toxicity and quality of life considerations in advanced ovarian cancer.

Authors:  J P Guastalla; V Diéras
Journal:  Br J Cancer       Date:  2003-12       Impact factor: 7.640

10.  Baseline FACT-G score is a predictor of survival for advanced lung cancer.

Authors:  M Dharma-Wardene; H J Au; J Hanson; D Dupere; J Hewitt; D Feeny
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.